Market ExpansionThe acquisition of Cohealyx, a collagen-based dermal matrix product, is expected to triple Avita's addressable market in burns.
Product PortfolioThe company's expanding portfolio is expected to lead to a transformational 2025 with revenue growth acceleration and profitability milestones.
Revenue GrowthAvita is forecasting remarkable revenue growth of 55-65%, a significant acceleration from previous performance, and has outlined plans to achieve key profitability metrics.